HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
The primary objective of our visit in Korea and China was to engage with our existing clients, forge new business relationships, and explore opportunities for expanding our market presence in these regions.
HTL was pleased to share the latest news from its team, who were in Asia to expand the company’s business in the region.
HTL was delighted by the warm welcome that its team and products received, first in Korea and then in China.
HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.